 Use during pregnancy may result in harm to the baby.It is a tyrosine-kinase inhibitor and works by blocking a number of tyrosine kinases such as Bcr-Abl and the Src kinase family.Dasatinib was approved for medical use in the United States and in the European Union in 2006.